Clinical Trial Detail


Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at :

NCT ID NCT03335540
Title An Adaptive Study to Match Patients With Solid Tumors to Various Immunotherapy Combinations Based Upon a Broad Biomarker Assessment
Recruitment Active, not recruiting
Gender both
Phase Phase I
Variant Requirements No
Sponsors Bristol-Myers Squibb

Advanced Solid Tumor


BMS-986205 + Nivolumab

Nivolumab + Relatlimab

Cabiralizumab + Nivolumab

Lirilumab + Nivolumab

BMS-986156 + Nivolumab

Ipilimumab + Nivolumab


Age Groups: adult | senior
Covered Countries USA

Facility Status City State Zip Country Details
The University of Chicago Medicine Chicago Illinois 60637 United States Details
University of Chicago Chicago Illinois 60637 United States Details
John Hopkins University Baltimore Maryland 21287 United States Details
UPMC Hillman Cancer Center Pittsburgh Pennsylvania 15232 United States Details
*Shaded cells indicate that there was no data available from for the field